Improving a Polygenic Risk Score (PRS) for Breast Cancer (BC) Risk Assessment in Diverse Ancestries
Association of Polygenic-based Breast Cancer Risk Prediction with Patient Management
Screening for 22q11.2 Deletion Syndrome With a pcfDNA Assay that Incorporates Fetal Fraction Amplification: Prenatal Ultrasound Findings and Pregnancy Outcomes
Use of Virtual Patient Education to Improve Provider Compliance with Hereditary Cancer Risk Assessment Guidelines and Genetic Testing in a Community OB/GYN Setting
Use of Virtual Patient Education to Improve Patient Understanding of Hereditary Cancer Risk Assessment and Genetic Literacy
Pregnancy and fetal outcomes in pregnancies that screened positive for rare autosomal trisomies (RATs)
Postpartum depression pharmacotherapy treatment patterns in two US claims databases
Design of high-performance tumor-informed molecular residual disease (MRD) panels from low FFPE tumor input
Impact of Combinatorial Pharmacogenomic Testing on Hospitalization Rates in a Real-World Dataset of Patients with Major Depressive Disorder
High positive predictive value of 22q11.2 microdeletion screening by prenatal cell-free DNA testing that incorporates fetal fraction amplification.
Title
Product
Journal / Conference
Year
Type
ID
Search recent publications from Myriad authors and contributors.